English
Français
Русский
Polski
Deutsch
日本語
简体中文
繁體中文
Português
Italiano
Small
Medium
Large
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
|
X
|
Y
|
Z
Anchorage
Austin
Beijing
Berlin
Boston
Brussels
Charleston
Charlotte
Chicago
Dallas
Doha
Dubai
Fort Worth
Frankfurt
Harrisburg
Hong Kong
London
Los Angeles
Miami
Milan
Moscow
New York
Newark
Orange County
Palo Alto
Paris
Pittsburgh
Portland
Raleigh
Research Triangle Park
San Diego
San Francisco
São Paulo
Seattle
Shanghai
Singapore
Spokane
Taipei
Tokyo
Warsaw
Washington DC
View all Practices by Topic
View All Practices Alphabetically
Publications
News
Events
Multimedia
Lawyers
Administrative Staff
Overview
Our Practice
Our Approach to the Markets
Our Technological Advantage
Our Ethic of Intergenerational Excellence
Our Commitment to Diversity and Inclusion
Our Engagement in Pro Bono and Public Service
Our Governance
People. Places. Practices.
SM
Representative Clients
Recognitions
Media Center
Anna H. McLaughlin
Associate
Charlotte
+1.704.331.7518
Fax
+1..704.353.3218
V-card
Download PDF
Publications
Brave New World at the General Assembly: The United Nations Declaration on Human Cloning
Minnesota Journal of Law, Science & Technology
Articles
December 2007
Primary Practice
Corporate
Secondary Practices
Corporate Governance
Education
J.D., Vanderbilt Law School, 2008, (
Vanderbilt Law Review,
Senior Managing Editor)
B.A., University of Virginia, 2005, (with distinction, Phi Beta Kappa)
Admissions
Bar of North Carolina
Ms. McLaughlin is an associate in the Charlotte office and focuses her practice on mergers and acquisitions, private equity transactions and general corporate matters. She represents private and public companies and private equity funds in various matters, including acquisitions, divestitures, securities issuances, recapitalizations and corporate governance matters.
Professional/Civic Activities
Pregnancy Resource Center, Volunteer
Tennessee Center for Bioethics and Culture, Board Member (2008-2010)
Represented a Fortune 50 industrial manufacturing company in the sale of its California commercial distribution business.
Represented a global provider of data processing services in its $2.1 billion acquisition of a software company.
Represented a private equity sponsor in its disposition of a regional automotive services franchisor.
Represented a biopharmaceutical company in connection with its recapitalization transaction and private placement financing.